
2025 ACMT Psychedelics Seminar
Includes Multiple Live Events. The next is on 10/10/2025 at 10:00 AM (EDT)
-
Register
- Non-member - Tier I - $450
- Non-member - Tier II - $400
- Non-member - Tier III - $350
- Non-member - Tier IV - $300
- Member - Tier I - $350
- Member - Tier II - $300
- Member - Tier III - $250
- Member - Tier IV - $200
ACMT Psychedelics Seminar
Fridays in October 2025: 10/10 & 10/17
10-5pm ET, Virtual Course, Live Zoom Event
Explore the evolving science, clinical applications, and complex realities of psychedelics in the 2025 ACMT Psychedelics Seminar, a two-day virtual course designed for healthcare professionals, clinicians, and toxicologists.
Held over two Fridays in October, this immersive course provides a comprehensive foundation in the pharmacology, toxicology, and therapeutic uses of psychedelics, while critically examining their place in today’s healthcare landscape.
Course Themes:
- Psychedelics 101: Pharmacology & Foundations
- Clinical Applications
- Adverse Effects, Safety, and Ethics
- Policy, Practice & Real-World Implementation
Over two days, participants will explore the pharmacology of classic psychedelics—including psilocybin, ayahuasca, mescaline, and LSD—as well as the therapeutic potential of ketamine, ibogaine, MDMA, and other novel psychotherapies. The course will review current evidence on psychedelics for treating substance use disorders, depression, PTSD, anxiety, and emerging areas such as dementia and Parkinson’s disease. Sessions will address the shifting legal and regulatory landscape, highlighting lessons from Oregon and Colorado’s psilocybin programs, the rapid growth of ketamine clinics, and the realities of microdosing.
Throughout the seminar, faculty will emphasize safety, adverse effects, drug interactions, and emerging designer substances, while engaging participants in critical conversations about indigenous knowledge, ethical access, and responsible integration of psychedelics into modern healthcare.
Registration for this activity includes two-days of live virtual event programming, 90 day access to the on-demand recordings after the live event, and 9.00 Continuing Education credits.
Target Audience
This seminar is designed for healthcare professionals and researchers interested in medical toxicology, addiction medicine and the emerging role of psychedelics in therapeutic settings, including:
- Physicians
- Pharmacists
- Nurses and Nurse Practitioners
- Physician Assistants
- Clinicians and Specialists in Poison Information
- Addiction Counselors and Mental Health Professionals
- Researchers
- Fellows, Residents, and Students

Continuing Education
Live and Enduring continuing education credits for Physicians, Pharmacists, and Nurses is provided by AKH Inc., Advancing Knowledge in Healthcare. It is expected that learners will receive up to 9.0 credits for learning and change.
Learner Objectives
After Completing This Program You Should Be Able To:
- Describe the pharmacology and toxicology of classic and emerging psychedelics, including psilocybin, ketamine, ibogaine, and MDMA.
- Evaluate current research on the clinical use of psychedelics in treating substance use disorders, mental health conditions, palliative care, and special populations.
- Analyze the adverse effects and safety considerations associated with psychedelic use.
- Identify practical strategies, legal factors, ethical considerations, and systemic barriers to integrating psychedelic-assisted therapies into existing treatment frameworks.
Questions?
Please write to ACMT at events@acmt.net

Maryann Amirshahi, PharmD, MD, MPH, PhD, FACMT (Moderator)
Emergency Medicine Attending Physician, Professor Of Emergency Medicine, Co-Medical Director
MedStar Washington Hospital Center, Georgetown University Hospital, National Capital Poison Center
Dr. Maryann Amirshahi is a Professor of Emergency Medicine at Georgetown University School of Medicine and practices clinically at MedStar Washington Hospital Center, where she specializes in toxicology, addiction care, and emergency medicine. She holds a PharmD and medical degree, alongside an MPH focusing on environmental and occupational health, and a PhD in pharmacology and public health. Dr. Amirshahi is board-certified in emergency medicine, medical toxicology, addiction medicine, and clinical pharmacology, and is a registered pharmacist with over a decade of practice. Nationally recognized, she serves on the Board of Directors for the American College of Medical Toxicology and as co-medical director of the National Capital Poison Center. With nearly 200 peer-reviewed publications, her research spans medication safety, drug shortages, addiction treatment, and prescription drug misuse.
Robert Hendrickson, MD, FACMT (Moderator)
Professor of Emergency Medicine, Medical Director, Program Director
Oregon Health and Science University, Oregon Poison Center, OHSU Fellowship in Medical Toxicology
Dr. Hendrickson graduated from the State University of New York, Downstate College of Medicine, and completed training in Emergency Medicine and Medical Toxicology at the Medical College of Pennsylvania. He is a Professor of Emergency Medicine at Oregon Health and Sciences University where he is Chief of the Section of Medical Toxicology, Program Director for the fellowship in medical toxicology, and the Medical Director of the Oregon Poison Center.

Shana Kusin, MD, FACMT (Moderator)
Associate Professor of Emergency Medicine
Oregon Health & Science University
Dr. Shana Kusin is an Associate Professor of Emergency Medicine at Oregon Health & Science University (OHSU), where she has served as full-time faculty since 2013 following her fellowship in Medical Toxicology at OHSU and the Oregon Poison Center. She sees patients in both the OHSU and Doernbecher Emergency Departments. Dr. Kusin’s academic interests center on medical toxicology—particularly drugs of abuse and plant- and animal-based toxins—as well as leveraging electronic health records to improve community-wide healthcare through information sharing and clinical decision support.

Evan Schwarz, MD, FACMT (Moderator)
Associate Professor of Emergency Medicine
University of California, Los Angeles
Dr. Schwarz attended medical school at the University of Texas Medical Branch in Galveston, Texas, before completing a residency in Emergency Medicine at the Washington University School of Medicine in Saint Louis, Missouri. After residency, he completed a fellowship in Medical Toxicology at the University of Texas Southwestern School of Medicine in Dallas, Texas, before returning to Missouri where he was an Advisory Dean and the Medical Toxicology Division Chief and Fellowship Director at Washington University. In 2023, he took a position in the Department of Emergency Medicine at the University of California Los Angeles. He is also a member of the Board of Directors for ACMT.
Registration Rates
Registration includes:
- Access to the live virtual events on October 10, 2025 and October 17, 2025
- Access to the on-demand recording for 90 days after the live virtual events
- Access to the speaker slides
- 9.0 Continuing Education credits for Physicians (CME), Pharmacists (CPE) or Nurses (CNE)
Member Rates
Member Tier I: Full, Affiliate, International, Emeritus |
$350 |
Member Tier II: Fellows |
$300 |
Member Tier III: Residents, International - Developing Country |
$250 |
Member IV: Medical Students |
$200 |
Non-Member Rates
Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other" |
$450 |
Non-member Tier II: Fellows, SPIs, Nurses, etc. |
$400 |
Non-member Tier III: Educators & Emergency Responders |
$350 |
Non-member IV: Residents & Students |
$300 |
ACMT Membership
ACMT Members receive a discounted rate. Interested in becoming an ACMT Member? Contact our Membership Team at membership@acmt.net. Learn more at: www.acmt.net/membership
Refunds and Cancellations
For information on ACMT's Cancellation and refund policy, click here.
Questions?
For any questions, please email us at events@acmt.net.
Instructions
Once you have completed your registration:
- Click on the Contents tab and attend the live events.
- Complete the Post-Test. These questions are based on content from the lectures to gauge your comprehension. It requires a 80% to pass.
- Complete the CE Survey. These questions are required to claim your CE certificate.
- Claim your CE certificate. Once you have claimed your CE credit, you will not be able to change your CE certificate.
Full credit can only be claimed after completion of all required components.
Hardware/Software Requirements
Computer or Other Internet-Enabled Device; Internet Connection; Browser.
Materials
None.
Prerequisites
None.
Format
This is a live, virtual course.
Need Assistance or Have Questions?
For assistance logging in, accessing content, purchasing or completing Continuing Education credits, or for other questions, please contact us at events@acmt.net or visit our FAQ page.
If you are in need of accessible learning accommodations, please contact events@acmt.net for additional assistance.
Continuing Education

2025 ACMT Psychedelics Seminar, Live Virtual Event
Please claim your continuing education credits within 30 days of the live event: November 17, 2025
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.
Criteria for Success
To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at events@acmt.net. If you have questions about this CE activity, please contact AKH Inc at bethany@akhcme.com

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 9.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Physicians: AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 9.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: Credit being awarded: 9.0 ANCC contact hours.
Pharmacists: AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 9.0 contact hour
Key:




